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Abstract 
Healthcare, as a basic human right, did not remain immune to innovative technologies. 
Technological progress has significantly contributed to high-quality, on-time, acceptable and 
affordable healthcare. Since their appearance, nanotechnology and the Internet of Nano 
Things (IoNT) have continuously affected healthcare and have a tremendous influence on 
its transformation, contributing to the better outcome. The inclusion of nanotechnology in 
medicine through nanomaterials and nanodevices, known as nanomedicine, has brought 
numerous benefits in disease prevention, diagnosis, and treatment. Going further by 
connecting nanodevices to the Internet, the IoNT paradigm has been created. The inclusion 
of IoNT concepts in healthcare has resulted in more personalized, timely, and convenient 
health monitoring and treatment. Hence, nanotechnology and the IoNT hold the potential to 
completely revolutionize healthcare in the 21st Century, creating a system that will enable 
early disease detection and diagnosis followed by accurate, on-time and effective treatment 
with significantly reduced healthcare costs. This paper presents the roles of nanotechnology 
and IoNT in medicine and healthcare, and attempts to gain an insight of nanoscale 
solutions and approaches, highlighting benefits and discussing potential risks and concerns. 
Despite concerns regarding nanotoxicity, privacy and security issues, it is anticipated that 
nanotechnology and IoNT will show their full potential in medicine and healthcare in the 
years to come. 
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Resumen 
La salud, como derecho humano básico, no ha permanecido inmune a las tecnologías 
innovadoras. El progreso tecnológico ha contribuido significativamente a un servicio de 
salud de alta calidad, aceptable y asequible. Desde su aparición, la nanotecnología y el 
Internet de las Nanocosas (IoNT, por sus siglas en inglés) han cambiado la atención médica 
y han influenciado tremendamente su transformación para obtener mejores resultados. La 
inclusión de la nanotecnología en medicina a través de nanomateriales y nanodispositivos se 
conoce como nanomedicina. Esta ha brindado numerosos beneficios a la prevención, 
diagnóstico y tratamiento de enfermedades. Al ir más allá y conectar los nanodispositivos a 
Internet, nació el paradigma del IoNT. La inclusión de conceptos del IoNT en los servicios de 
salud ha resultado en monitoreo y tratamiento más personalizados, oportunos y 
convenientes. Por estos motivos, la nanotecnología y el IoNT tienen el potencial para 
revolucionar completamente la asistencia médica en el siglo XXI, creando un sistema que 
permitirá la detección y diagnóstico tempranos de enfermedades, seguidos por un 
tratamiento preciso, oportuno y efectivo con costos significativamente menores.  Este 
artículo presenta el papel que la nanotecnología y el IoNT tienen en medicina y los servicios 
de salud. Además, intenta ampliar el conocimiento sobre las soluciones y enfoques a 
nanoescala, resaltando los beneficios y analizando los riesgos y preocupaciones potenciales. 
A pesar de los miedos relacionados con la nanotoxicidad y privacidad, se anticipa que la 
nanotecnología y el IoNT muestren todo su potencial en el campo de la medicina y la salud 
en los próximos años. 
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1. INTRODUCTION 
 
As a technology that has enabled sci-
ence and engineering on the 10-9 scale, 
nanotechnology has resulted in the devel-
opment of nanoparticles, nanomaterials, 
nanoscale electronic and sensing devices, 
and it is considered to be the technology of 
the 21st Century. Technological advances 
have enabled nanodevices, composed of 
nanocomponents, to perform simple tasks 
such as sensing or actuation and to be 
connected to the Internet through seamless 
communication and information transmis-
sion. This technological progress has creat-
ed a vision, namely the Internet of Nano 
Things (IoNT) [1], which combined with 
the advancements in nanotechnology will 
revolutionize almost every field of our 
lives. 
Nanotechnology and the IoNT already 
have significant roles in numerous applica-
tions across diverse sectors, such as agri-
culture and food, environment protection, 
electronics, energy and biomedicine, among 
others. Their widespread utilization in 
medicine and healthcare holds the poten-
tial to bring the greatest benefits to the 
society, creating a new generation of medi-
cine, known as nanomedicine. According to 
[2], nanomedicine can be simply defined as 
applying nanotechnology to biology in med-
ical applications. The more detailed defini-
tion states that nanomedicine is an inter-
disciplinary scientific discipline that in-
volves medicine, physics, biology, chemis-
try, engineering and optics for disease 
diagnostic and treatment processes by 
means of nanotechnology [2]–[4]. Empow-
ering nanomedicine with the IoNT will 
make revolutionizing changes in disease 
prevention, diagnosis, and treatment. In 
other words, the ability to detect and make 
a diagnosis at the early stage of the dis-
ease, precise and effective treatment, the 
promise to cure the life-threatening dis-
eases, saving a great number of lives as 
well as extended average lifespan justify 
the worldwide attention to nanotechnology 
and IoNT research and development [5]. 
As it is anticipated that in the next few 
years there will be no aspect of life un-
touched by nanotechnology and the IoNT, 
they receive growing worldwide attention. 
New and enhanced properties and func-
tionalities are the results of production of 
novel nanomaterials and nanodevices. This 
means that the new ways to synthesize 
nanoparticles and create nanomaterials 
[6]–[20], the analysis of nanoparticles’ and 
nanomaterials’ potential toxicity [12], [20]–
[30], the development of novel nanodevices, 
nanosensors and nanocommunication [13], 
[18], [20],[31]–[35], and the implementa-
tion of green practices in nanotechnology 
and the IoNT [11], [24],[36]–[41] are some 
of the current most interesting  topics to 
research. The particular interest in nano-
technology and the IoNT consists in the 
fact that they have opened a whole new 
world of potential remarkable improve-
ments in medicine and healthcare. In addi-
tion, it is forecasted that the global nano-
technology market will grow at a CAGR 
(Compound Annual Growth Rate) of 
around 17 % during the 2017-2024 period, 
while the IoNT and nanomedicine markets 
will grow at a CAGR of 22.81 % from 2016 
to 2020, and 12.3 % from 2013 to 2019, 
respectively [26], [42]. These facts will 
consequently lead to potentially huge rev-
enue based on the commercialization of 
nanotechnology and the IoNT. 
All the above-stated facts justify the in-
creasing interest in research devoted to the 
implementation of nanotechnology and the 
IoNT in medicine and healthcare. For that 
reason, this paper presents an attempt to 
obtain as much knowledge and insight as 
possible regarding this topic. For reviewing 
the roles of nanotechnology and the IoNT 
in healthcare transformation, a systematic 
search of relevant literature was conducted 
on the following online databases: EBSCO, 
Scopus and Science Direct. In addition, 
Google Scholar and Research Gate were 
also used as appropriate subject-related 
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information sources. However, the scien-
tific papers used in this survey are by no 
means exhaustive and they have been used 
for illustrating, as much as possible, the 
current state of the application of nano-
technology and the IoNT in healthcare. As 
the review is aimed at analyzing the roles 
and benefits nanotechnology advance-
ments bring in medicine and healthcare, a 
combination of quantitative and qualita-
tive research methodologies was imple-
mented. The review of papers related to 
nanotechnology, nanomedicine, the IoNT 
and their correlations have more clearly 
shown the importance of innovative nano-
technology approaches in medicine and 
healthcare. One of the main contributions 
of the performed survey is the SWOT 
(Strengths, Weaknesses, Opportunities, 
and Threats) analysis, which helps to thor-
oughly understand the roles of nanotech-
nology and the IoNT in healthcare trans-
formation. Despite the weaknesses and 
risks (mostly related to potential toxicity of 
nanomaterials, privacy and security issues 
of the IoNT), the stated benefits—patient-
tailored, accurate, on-time, accessible and 
affordable healthcare—justify the necessi-
ty for further development and innovations 
in nanomedicine. There are also numerous 
opportunities for nanotechnology and the 
IoNT, powered by medicine and 
healthcare, that will undoubtedly lead to 
further benefits and the revolutionization 
of healthcare. Therefore, the rest of the 
paper is structured as follows. Section 2 
highlights nanotechnology applications in 
medicine, while Section 3 is devoted to the 
IoNT paradigm implementation for 
healthcare purposes. The benefits of nano-
technology and the IoNT, as well as the 
challenges, risks, and concerns regarding 
their implementation in medicine and 
healthcare, are discussed in Section 4. This 
section also presents the SWOT analysis of 
nanotechnology and IoNT utilization in 
healthcare transformation. Finally, the 
last section presents concluding remarks 
and future possible directions in nanotech-
nology and IoNT applications in the next 
generation of medicine and healthcare. 
 
 
2. NANOMEDICINE AS MEDICINE OF THE 
FUTURE 
 
Nanomedicine may be defined as the 
use of nanodevices and nanostructures for 
monitoring, repairing or controlling human 
biological systems at the molecular level. 
Engineered nanodevices and nanostruc-
tures used in medicine and healthcare can 
be classified into 4 categories: 
 
 1st-generation products (2000): dis-
persed and contact nanostructures (e.g., 
colloids) as well as product incorporat-
ing nanostructures (e.g., nanostructured 
metal, polymers). 
 
 2nd-generation active nanostructures 
(2000-2005): physical-chemical active 
adaptive structures (e.g., actuators, am-
plifiers) and bio-active devices (e.g., bio-
devices, targeted drugs). 
 
 3rd-generation nanosystems (2005-
2010): robotics, evolutionary biosystems. 
 
 4th-generation molecular nanotechnolo-
gy and nanosystems (2010-2020): mo-
lecular devices by design and molecular 
structures that could serve as a founda-
tion for regeneration or replacement of 
lost body parts. 
 
Nanomedicine currently utilizes a vari-
ety of nanomaterials and nanodevices de-
signed to perform certain functions in the 
biological environment with nanoscale 
precision, such as: nanoparticles, na-
nochips, nanorobots, quantum dots, nano-
valves, etc. [2]. The dominant research and 
development fields in nanomedicine that 
are discussed in the rest of the paper focus 
on biopharmaceutics, antimicrobial proper-
ties, implants (implantable materials and 
devices), and diagnostic tools. 
The roles of nanotechnology and internet of nano things in healthcare transformation 
TecnoLógicas, ISSN-p 0123-7799 / ISSN-e 2256-5337, Vol. 20, No. 40, sep-dic de 2017, pp. 139-153 [143] 
2.1 Biopharmaceutics 
 
The utilization of nanoparticles as drug 
delivery systems has already shown great 
success. As nano-enhanced drug delivery 
products already are a commercial reality, 
drug delivery is a dominant research field 
in nanomedicine. The development of 
nano-based drug delivery systems includes 
the use of nanoscale particles/molecules 
(that have unique medical effects according 
to their structure) to encapsulate the drug, 
deliver it to the target places and release it 
in controlled ways in order to repair dam-
aged cells. Drug delivery systems are 
mainly used for treating neurological dis-
orders (e.g., Alzheimer’s and Parkinson’s 
diseases), HIV/AIDS (Human Immunodefi-
ciency Virus infection / Acquired Immune 
Deficiency Syndrome), and cancer. There 
are several nanoparticle drug delivery 
systems used in nanomedicine that come in 
various shapes and sizes: biological nano-
particles, polymersome nanoparticles, 
lipid-based drug delivery systems, micelle 
nanoparticles, etc. Nanovalves, tiny valves 
placed in the pores of nanostructures, are 
also used for drug delivery. Nanoscale 
silica and calcium phosphates are exam-
ples of materials that are used for encapsu-
lating drugs in order to protect them dur-
ing transportation inside the body [2]. 
Liposomes (and virosomes), nanosuspen-
sions, polymeric nanoparticles, den-
drimers, fullerenes, carbon nanotubes, 
inorganic nanoparticles, and nanoshells 
are examples of nanoscale parti-
cles/molecules that are developed to im-
prove the bioavailability and pharmacoki-
netics of therapeutics. Engineered nano-
particles sensitive to certain pH values 
have proven to be the best means to deliver 
drugs avoiding invasive treatments. pH-
responsive nanoparticles in contact with 
the appropriate pH surroundings release 
the drug, which makes them of particular 
interest for drug delivery to specific cells, 
tissues or organs [10]. The utilization of 
gold nanoparticles conjugated with or 
without antibiotics holds the potential to 
improve the delivery (targeting and dos-
age) of antibiotics. The synthesis and utili-
zation of gold nanoparticles are discussed 
in detail in [17], while the authors of [15] 
and [16] highlight the application of na-
nosilver particles in medicine. It is im-
portant to note that gold nanoparticles 
conjugated with conventional drugs can 
minimize side effects of drugs [14]. Like-
wise, silver nanoparticles show positive 
effects in various wound treatments (e.g., 
burns, chronic ulcers, toxic epidermal 
necrolysis, and pemphigus) which mainly 
consists in significantly shorter wound-
healing time [16]. Copper oxide nanoparti-
cles also show antimicrobial ability, which 
implies their application in disinfecting 
surfaces and medical devices as well as 
antimicrobial wound dressings, textiles 
and coatings [13]. Silver nanoparticles can 
be used for drug delivery of therapeutic 
agents in eye care for coating contact 
lenses [15]. Targeted delivery of peptides 
or DNA (deoxyribonucleic acid), as well as 
detection and photothermolysis of microor-
ganisms and cancer cells are other exam-
ples of gold nanoparticles usage in biomed-
icine [17]. Cancer is one of the leading 
causes of death in the world, but at the 
same time, it is the largest therapeutic 
area where nano-enabled products have 
made major contributions. 
Silver nanoparticles are used in the di-
agnosis and treatment of cancer. Similarly, 
the usage of gold nanoparticles functional-
ized with targeted specific biomolecules 
can effectively destroy cancer cells or bac-
teria [14]. In other words, gold nanoshells 
are being used to fight cancer in such way 
that, after entering tumor cells and apply-
ing radiation treatment, they absorb ener-
gy and heat up enough to kill the cancer 
cells with minimum harm to the surround-
ing healthy cells. Other factors can also be 
engaged in fighting cancer, like magnetic 
nanoparticles that bind to cancer cells 
present in the bloodstream, thus allowing 
the removal of cancer cells before they 
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establish new tumors. Authors of [10] state 
the importance of magnetic nanoparticles 
utilization in magnetic field hyperthermia, 
which has shown to be a promising and 
more effective technology in cancer treat-
ment. Thermosensitive yolk-shell nanopar-
ticles were developed and presented in [9] 
as an innovative remote-controlled target-
ing drug delivery platform for multimodal 
imaging and combined cancer therapy, 
while authors of [18] present the possibili-
ties of platinum nanoparticles utilization 
for treatment of several types of cancer. 
Camptothecin, Doxorubicin, Paclitaxel, 
Vincristine and Etoposide, as naturally 
occurring anti-cancer drugs, are presented 
and analyzed in [43]. Authors of [44] pre-
sent albumin-based nano-enabled ap-
proaches for their potential use in cancer 
diagnosis and therapy. Shell-stacked na-
noparticles with enhanced tumor penetra-
tion and uptake by cells in deep tumor 
tissue are presented in [45]. The antimi-
crobial, magnetic and optic activities of 
Fe3O4AuxAgy nanoparticles justify their 
usage in anticancer drug delivery since, at 
the same time, they enable to observe what 
happens to the cancerous cells without 
damaging healthy ones [19]. 
Based on the results achieved in 
fighting cancer, mainly the utilization of 
nanoparticles in cancer treatment, there is 
a belief that nanomedicine holds potential 
for defeating cancer for good [2]. The rea-
son for this lies in the fact that nanodevic-
es are faster and more sensitive than tra-
ditional drug delivery systems. They are 
able to deliver very strong drugs, with 
controlled release directly to a target place 
within the body without causing any side 
effects. Therefore, the benefits of targeted 
medicine consist of significantly decreased 
drug consumption, better patient care, less 
invasive drug delivery and cost-effective 
treatments [46]. However, there are nu-
merous technical challenges for developing 
techniques for controlling sensitive drugs 
(targeting and triggering), nanochips for 
nanoparticle release, virus-like system 
creation for intracellular systems, etc. [8]. 
 
2.2 Implants 
 
Nanomaterials and nanocomponents 
have increasingly been used as implanta-
ble materials and devices. Nanotechnology 
enables the development of nanomaterials 
and coatings that increase the adhesion, 
durability and life of implants in tissue 
repair and replacement applications. 
Nanostructures are also being used to 
prepare and improve tissue regeneration 
scaffolds. Alongside soft tissue implants, 
nanotechnology plays a central part in the 
evolution of hard tissue implants, bone 
substitute materials, and dental restora-
tives. Bone repair materials (e.g., calcium 
phosphate apatite, hydroxyapatite) and 
bioresorbable and smart materials (that 
respond to changes in the environment) 
are examples of nanomaterials used as 
structural implant materials [2]. As such, 
nanomaterials have greater biocompatibil-
ity and promote new bone growth [1]. Sil-
ver nanoparticles have proven to be an 
appropriate surface coating for stents and 
heart valves because of their anti-
thrombogenic and antibacterial properties. 
Besides, their usage as catheter coating 
significantly helps to reduce bacterial 
growth. Coating contact lenses is another 
example of the applications of silver nano-
particles, thanks to their increased re-
sistance to bacteria. The additional power 
of silver nanoparticles to maintain or in-
crease the shear bond strength makes 
them suitable to be applied to dental in-
struments and bandages, as well as ortho-
pedic and orthodontic implants and fixa-
tions [16]. 
The improvement of the orthopedic im-
plant’s lifespan can be also achieved by 
using carbon nanotubes [10]. Nevertheless, 
the utilization of implantable nanosensors 
enables more effective detection of a tar-
geted chemical or physical attribute. Im-
plantable nanomedical devices or na-
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nomachines deployed inside the human 
body can perform actions according to de-
mands or be remotely controlled from the 
macro scale and over the Internet by an 
external user (a healthcare professional) 
[1]. Nanotechnology also enables the devel-
opment of surgical instruments and robots 
that enable performing microsurgeries in a 
precise and accurate way. Surgery visuali-
zation can be improved by using nanocam-
eras, while computers can be used to con-
trol the nano-sized surgical instruments. 
This way, surgery can be performed at 
tissue, genetic and cellular levels with a 
significantly reduced chance of mistakes. 
Although nanosurgery research is still in 
very early stages, it is a potential future 
application of nanoscience. Already com-
mercially available nanoneedles, nanot-
weezers, nanorobots and precision lasers 
will contribute to the realization of the 
nanosurgery vision [47]. Nanomaterial-
based medical devices have been presented 
in detail in [20]. The utilization of medical 
nanomachines for destroying kidney 
stones, nanorobots for cleaning lungs, ar-
teries, teeth or nanorobots that support the 
regeneration of skin, organs (e.g., repairs 
of gastrointestinal and abdominal tissue) 
or bones (repair of bone defects and frac-
tures) are closer to reality and widespread 
use than ever before [2], [4]. 
 
2.3 Diagnostic tools 
 
The utilization of nanotechnology for 
clinical diagnostic purposes is referred to 
as nanodiagnostics. There are numerous 
types of nanoparticles that enable detec-
tion of pre-cancerous cells, a fragment of 
viruses, specific proteins, antibodies and 
other markers and indicators of disease 
[48]. Quantum dots, very small semicon-
ductor particles, hold potential for creating 
disease detection systems that are more 
sensitive and accurate [2]. The utilization 
of novel sensors and lab-on-a-chip concepts 
based on nanotubes, nanowires, cantilevers 
or atomic force microscopy for diagnostic 
purposes improve the sensitivity and ena-
ble faster and more accurate diagnostics 
alongside reduced costs. For example, car-
bon nanotubes and gold nanoparticles used 
in sensors enable the detection of oral can-
cer indicators; nanoparticles called 
NanoFlares are used to discover cancerous 
cells in the bloodstream; and silver nano-
rods in a diagnostic system hold potential 
for separating viruses, bacteria and other 
microscopic elements of blood samples, etc. 
Furthermore, in vivo imaging can be per-
formed using nanoparticle contrast agents, 
mainly for MRI (Magnetic Resonance Im-
aging) and ultrasound, or using miniature 
imaging devices like a pill containing a 
miniature video system that takes pictures 
throughout the whole digestive system. 
Iron oxide nanoparticles, thanks to their 
unique size and half-life, have proven to be 
the adequate contrast agent for improved 
detail in MRI, particularly for more accu-
rate diagnosis of problems associated with 
the circulatory system [10]. Perfluorocar-
bon emulsion nanoparticles (PFC) help to 
increase the contrast of the image created 
by ultrasonography, improving its quality. 
This is of particular interest in medicine 
because ultrasonography is more economi-
cal than other noninvasive imaging tech-
nologies and can help with diagnosis, par-
ticularly when imaging tumors [10]. The 
utilization of fluorescent platinum 
nanoclusters as new biocompatible bioim-
aging probes for diagnostic purposes has 
been presented in [18]. Platinum nano-
materials have also been used for making 
molecular machines and motion-based 
detection methods. A more detailed analy-
sis of diagnostic and therapeutic tech-
niques using nanoparticles is performed in 
[20]. Hence, the application of nanoparti-
cles and nanomaterials to imaging and 
visualization holds potential for faster, 
more sensitive and cost-effective diagnostic 
practices [4]. 
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3. INTERNET OF NANO THINGS (IONT) IN 
MEDICINE AND HEALTHCARE 
 
The Internet of Things (IoT) is a net-
work of smart things/devices connected to 
the Internet and able to communicate with 
each other and with humans that has 
brought tremendous benefits in modern 
society. Further reduction of the size of 
devices to the nanoscale (from one to a few 
hundred nm) and their connection to the 
Internet have enabled the appearance of a 
paradigm, namely the Internet of Nano 
Things (IoNT). The IoNT is based on the 
usage of nanomachines, small components 
able to perform simple processing, sensing 
and control tasks that are used for the 
development of nanoprocessors, nanomem-
ories, nanobots and nanoclocks. Na-
nomachines are developed using the top-
down approach (self-assembly of molecular 
components), bottom-up approach (synthe-
sis of nanomaterials from atoms or mole-
cules) or bio-hybrid approach (design based 
on molecular signaling) [42]. Nanonodes 
used in nanomedicine are nanomachines 
composed of control and storage unit, 
communication unit, power unit, and a 
variety of sensors and actuators. Intercon-
nected nanonodes (devices able to sense, 
collect, process and store information) 
inside, on or outside the human body di-
rectly communicate via nanorouters and 
nano-micro interface devices with external 
devices, thus composing nanonetworks. 
Nanorouters, alongside data aggregation 
from nanonodes, also control the nan-
onodes by exchanging very simple control 
commands (on/off, sleep, read value, etc.). 
The remote control of the nanodevices over 
the Internet is performed via gateway 
devices (Fig. 1) [1], [49]–[51]. Regarding 
communication, radio frequency messaging 
in the 1-10 MHz is a possible way to send a 
message into a body, while most cell com-
munication uses chemical signals [2]. 
However, the uniqueness of nanodevices 
and nanonetworks implies the demand for 
new solutions for communicating with the 
outside world and between nanodevices. It 
is important to highlight that molecular 
communication is nano-electromagnetic 
and connects two nanodevices, transmit-
ting and receiving electromagnetic radio 
frequency waves in the THz band [42], 
[50].  
 
 
 
Fig. 1. Architecture of the IoNT in a healthcare application. 
Source: Akyildiz and Jornet [49].  
 
Nanonetworks utilization in medicine 
and healthcare is most present in na-
noscale surgeries, smart drug administra-
tion, and detection and management of the 
rapid spread of infectious diseases [50]. 
The IoNT paradigm enables doctors and 
healthcare providers to gain insights about 
the patient’s current health condition, as 
well as remotely monitor and control any 
sudden change in the body through the 
nanosensors or nanorobots embedded with-
in the patient’s body. Some examples are 
monitoring the blood glucose level, deliver-
ing a drug in case of need or monitoring 
the biomarkers of cancer [51]. The inclu-
sion of nanodevices and the IoNT in medi-
cine and healthcare enables access to hard-
to-reach areas and vital information at a 
whole new level (molecular information) 
[1]. In this manner, it is possible to detect 
diseases, make an accurate diagnosis ear-
lier and react faster than ever before, 
which significantly increases the chances 
of successful treatment and overcoming the 
diseases. 
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4. BENEFITS, CHALENGES, RISKS, AND 
CONCERNS REGARDING THE 
NANOTECHNOLOGY AND IONT 
UTILIZATION IN MEDICINE AND 
HEALTHCARE 
 
As can it be noted, the benefits of nano-
technology and the IoNT in medicine and 
healthcare are numerous. Earlier, faster, 
more accurate and sophisticated detection 
and diagnosis of different diseases, more 
effective disease treatment, enhanced mon-
itoring of patient health status and pre-
vention of diseases are the foundations of 
the next generation of medicine and 
healthcare, realized with the help of nano-
technology and the IoNT. Nanoparticles, 
nanosensors, nanorobots and other 
nanodevices connected in nanonetworks 
via the IoNT create a completely new envi-
ronment for the revolutionization of 
healthcare and medicine in the 21st Centu-
ry. Nanodiagnostics, nanosurgery, regen-
erative medicine, nanodentistry and na-
nomedicine are expected to be in wide-
spread use in years to come. 
Despite the numerous benefits that the 
medical use of nanotechnology and the 
IoNT have to offer, there is a justified con-
cern about their potential negative im-
pacts. Nanoparticles can be made of almost 
any material through various processing 
techniques and be of any shape and struc-
ture. The function and applications of na-
noparticles mostly depend on the nanopar-
ticle’s size [2]. Smaller nanoparticles are 
easier to clear from the bloodstream after 
the targeted nanoparticle therapy, but it is 
important to keep in mind that the smaller 
the particle, the more toxic it is. Besides, 
some types of nanomaterials may cause 
adverse reactions in patients. For this 
reason, nanotoxicology—as a research 
field—is increasingly important to under-
stand the risks of using nanomaterials and 
the cost of the resulting damage [36]. 
Inadvertently or intentionally applied 
to the human body (through skin nodes, 
respiratory system, via ingestion or im-
planting), nanoparticles and nanomaterials 
may cause numerous health-related prob-
lems, as indicated in Fig. 2. For that rea-
son, numerous research studies are devot-
ed to the analysis of the toxicology of vari-
ous nanoparticles applied to healthcare 
purposes: gold, silver, platinum, copper 
oxide, zinc oxide, silica and titania nano-
particles, quantum dots, manganese nano-
particles, fullerene, carbon nanotubes, 
inorganic nanoparticles, nanospheres, 
nanoshells and nanocapsules [18], [20], 
[24], [28], [29], [52]. Authors of [21] ana-
lyzed the environmental impact and poten-
tial health risks of 2D nanomaterials, 
mainly graphene-based materials, transi-
tion metal dichalcogenides and black phos-
phorus, mostly used for constructing elec-
trodes and electronic, photovoltaic, and 
sensing devices. Due to the rapid develop-
ment of nanotechnology and its utilization 
for healthcare purposes, there is a rising 
need for conducting toxicological studies of 
nanoparticles, nanomaterials, and 
nanosystems. Hence, both in-vitro and in-
vivo studies of the biological effects of na-
noparticles are mandatory. Some of the 
current methods used in nanotoxicity as-
sessment are presented in [27]. 
Therefore, regarding the intentional 
use of nanoparticles and nanomaterials for 
healthcare purposes, it is essential to find 
a balance between the safety of the nano-
particles and nanomaterials that are used 
and the efficiency of the treatment. Differ-
ent aspects of toxicology should be consid-
ered when nanoparticles and nanomateri-
als are being used for medical diagnosis 
and treatment. Hence, the main challenge 
for nanotoxicology is to determine the 
properties of nanoparticles that may cause 
significant adverse health effects when 
being applied to the patient during diag-
nostic or treatment procedures [30]. 
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Fig. 2. Potential harmful effects of nanoparticles to human health. Source: Maksimović and Omanović-Mikličanin [36]. 
There are numerous organizations that 
attempt to address nanotechnology toxicity 
to humans and the environment, such as 
the Organisation for Economic Co-
operation and Development (OECD), the 
National Institute for Occupational Safety 
and Health (NIOSH), the EU NanoSafety 
Cluster, the Federal Institute for Materials 
Research and Testing (BAM), the Federal 
Ministry of Education and Research 
(BMBF), Modena Cost and others [24]. 
However, there are no particular regu-
lations on nanoparticles apart from the 
existing ones covering similar materials in 
bulk. This represents the main challenge 
and obstacle in the evolution of nanotech-
nology. The complexity of nanoparticles, 
nanomaterials, and nanotechnology in 
general is the main reason for the lack of 
regulation and standards covering this 
scientific and research field. Although 
there is no specific regulatory framework 
for nanotechnology-based products, au-
thors of [26] presented their regulatory 
roadmap for nanotechnology-based ma-
chines. In order to become more aware of 
the potential harmful effects of nanotech-
nology on human health and the environ-
ment, extensive studies on nanomaterials’ 
interaction with biological systems and 
international collaborative research are 
required. In addition, there is a need to 
work extensively on developing nano-
specific regulations for developing and 
labeling nanoproducts [53]. However, it is 
important to mention some of the stand-
ard-setting groups that are involved in 
developing nanotechnology standards, such 
as the International Standardization Or-
ganization (ISO) Technical Committee (TC) 
229 on Nanotechnologies, the ASTM 
(American Society for Testing and Materi-
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als) the International Committee E56 
(Nanotechnology), the International Elec-
trotechnical Commission Technical Com-
mittee 113 (Nanotechnology Standardiza-
tion for Electrical and Electronics Products 
and Systems), and the Institute of Electri-
cal and Electronics Engineers’ Nanotech-
nology Council [53]. 
In order to reduce the negative aspects 
of nanotechnology, recent research is being 
focused on moving towards green nano-
technology. Green nanotechnology is based 
on green chemistry principles implemented 
in designing nanoscale products, the devel-
opment of nanomaterial production meth-
ods and nanomaterials utilization. Even 
though most of the potential of green nano-
technology solutions is still in the lab/start-
up phase [36], green nanotechnology is 
expected to bring numerous benefits across 
diverse sectors, including medicine and 
healthcare, mostly reducing the negative 
impacts of nanotechnology on human 
health and the environment. The produc-
tion of nanoparticles using green chemistry 
synthesis routes is environmentally friend-
ly and non-toxic, as well as cost-effective. 
The synthesis of nanoparticles can be per-
formed by plants, algae, bacteria, yeast, 
fungi, and human cells [37], [40], [54]. 
Authors of [39] present a variety of green 
methods for the synthesis of iron nanopar-
ticles based on plant extracts, fungi, bacte-
ria, amino acids, etc. There are also nu-
merous examples of using a variety of 
plants for the development of nanoparti-
cles, silver and gold nanoparticles particu-
larly. For example, leaf extracts of 
lemongrass, aloe vera and tamarind can be 
used for forming silver and gold nanoparti-
cles [37]. Besides, authors of [11] present 
ways to prepare gold nanoparticles                  
by using a natural biomaterial, egg shell 
membrane, high-power ultrasound, sodium 
dehydrate, and applying sunlight irradia-
tion methods or exposing edible mushroom 
to sunlight. A more detailed analysis of 
green nanoparticles synthesis, their char-
acteristics and applications are given in 
[38] and [54], where that green approach is 
clearly presented and mostly focused on 
the synthesis of metallic and bimetallic 
nanoparticles. Green synthesized nanopar-
ticles possess anticancer, antimicrobial and 
imaging properties what make them suita-
ble for diagnostic applications, drug deliv-
ery and anticancer activities [38], [54]. In 
addition, green synthesis of nanoparticles 
is less polluting and based on the utiliza-
tion of natural chemical-free products; 
then, the toxicity of nanoparticles is re-
duced compared to the “traditionally” pro-
duced nanoparticles. Low energy use and 
environmental impact alongside signifi-
cantly less side effects are additional bene-
fits of green synthesis of nanoparticles. 
However green nanoparticles are yet to be 
explored and improved and promise to 
bring about a huge potential in the treat-
ment of a variety of diseases. 
At the same time, the IoNT that holds 
the potential to revolutionize healthcare 
more than anything else before, also brings 
risks and challenges that must be consid-
ered. The IoNT enables to gain better in-
sights into health conditions, remotely 
monitor and control, and timely and accu-
rately respond to unexpected changes in 
the human body. Nevertheless, the prima-
ry concerns are security and privacy is-
sues. Health-related data are quite sensi-
tive and they have to be properly protect-
ed. To reduce the risk of any malicious 
attacks (e.g., disruption of medical applica-
tions that can harm or kill through drug 
delivery and radio communication [31]), a 
strong network security infrastructure for 
all ranges of communication (from 
nanodevices, router and gateway, further 
to the Cloud) is mandatory. Existing secu-
rity mechanisms and techniques are not 
suitable to secure nanodevices in nanonet-
works because they operate in the THz 
band. The fact that current security solu-
tions are not suitable for protecting the 
IoNT implies the necessity of new and 
appropriate security and privacy frame-
work and mechanisms, presented in vari-
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ous research works [31]-[34], [51]. Some of 
the proposed solutions are: checking the 
integrity of information by using checksum 
algorithms, using encryption algorithms to 
code information before transferring be-
tween nanodevices, critical data hiding 
algorithms, and multi-layer authentication 
to guarantee only authenticated user can 
access nanonetworks [51]. 
Table 1 presents an attempt to summa-
rize the Strengths, Weaknesses, Opportu-
nities, and Threats of nanotechnology and 
IoNT utilization in medicine and 
healthcare. 
In summary, the concerns regarding 
nanotechnology and IoNT utilization in 
medicine and healthcare, besides technical 
are also social, economic and ethical, such 
as: 
 Reducing the gap between humans 
and robots/computers; 
 The control of nanotechnology applied 
for medical purposes; 
 The evolution of nanomedicine and the 
provision of the same level and quality 
of nano-based healthcare to all, irre-
spective of ethnicity, race, gender or 
political viewpoints; 
 The nanotoxicity of nanoparticles and 
nanomaterials applied in healthcare; 
 The possibilities of using novel techno-
logical approaches to harm people; and 
 Standards and regulatory issues. 
 
 
Table 1. SWOT analysis - Nanotechnology and the IoNT in medicine and healthcare 
Strengths Weaknesses 
Earlier, faster and more accurate diagnostic processes 
Innovative and adequate therapies and painless treatments 
Reduced negative effects of drugs and surgical procedures 
New drugs and drug delivery systems 
Faster, smaller, highly-sensitive diagnostic and treatment 
tools (e.g. nanorobots, nanoneedles, nanotweezers, nanocam-
eras, etc.) 
Smart nanodevices connected to the Internet 
Real-time and remote monitoring of disease and treatments 
via the IoNT 
Significantly reduced medical and healthcare cost 
Persisting lack of proper knowledge regarding nanoparticles 
and nanomaterials reactions inside the human body 
Possible toxicity of nanoparticles and nanomaterials 
Privacy and security issues regarding health-related data 
Lack of standards and regulations 
Immature public awareness and understanding of nanotech-
nology and the IoNT (ethical concerns and trust issues) 
 
Opportunities Threats 
Significant progress in fighting numerous unsolved medical 
problems and diseases, such as cancer 
Reduction of mortality and morbidity rates, extension of 
patients’ lives 
Moving towards green nanotechnology and green IoNT holds 
the potential to create smarter, safer, and more sustainable 
medical practices 
Development of computational models that will predict 
toxicity and other potential side effects of nanomaterials 
used in medical and healthcare purposes based on the nano-
particles structures,  
Maximization of the return of Research and Development 
investments 
Security and privacy issues regarding nanonetworks are not 
fully addressed 
Concerns regarding control over nanotechnologies applied in 
medicine and healthcare 
The lack of proper mechanisms opens a potential utilization 
of nanotechnology and the IoNT to harm or kill 
Nanoparticles’ and nanomaterials’ toxicological behavior 
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5. CONCLUSIONS 
 
Nanotechnology, as the Second Industrial 
Revolution, has seemingly limitless poten-
tial to revolutionize all aspects of our lives. 
However, the most significant benefits can 
be expected in medicine and healthcare, 
where nanotechnology already shows nu-
merous advantages. Significantly en-
hanced disease diagnosis and treatment by 
means of nanotechnology promise to create 
a completely new generation of medicine 
and healthcare. Implementing IoT con-
cepts on the nanoscale contributes to more 
effective and accurate monitoring of health 
conditions, and consequently appropriate, 
adequate, and timely actions. Despite the 
numerous benefits of nanomedicine and 
the IoNT, there are also issues that have to 
be seriously taken into consideration. 
Nanotoxicity, privacy and security issues 
are the main concerns and main obstacles 
on the road to full implementation of nano-
technology and the IoNT in medicine and 
healthcare. Moving towards a greener 
future, increasing awareness regarding 
nanotechnology utilization, successfully 
dealing with nanotoxicity issues and devel-
oping security and privacy mechanisms in 
IoNT concepts promise that nanotechnolo-
gy and the IoNT will successfully replace 
traditional medical and healthcare practic-
es and techniques. A future in which green 
(nano) technologies and green chemistry 
principles are fully implemented will im-
portantly contribute to revolutionizing the 
healthcare of the 21st Century, making it 
more precise, on-time, accessible and af-
fordable than ever before. Healthier and 
longer lives are the main aims of the next 
generation of medicine and healthcare. 
Nanotechnology and the IoNT will un-
doubtedly play a major role in accomplish-
ing this goal. 
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